Free Trial
LON:ALT

Altitude Group (ALT) Share Price, News & Analysis

Altitude Group logo
GBX 24 -0.50 (-2.04%)
As of 07/10/2025 04:22 AM Eastern

About Altitude Group Stock (LON:ALT)

Key Stats

Today's Range
24
24.50
50-Day Range
20
25.48
52-Week Range
20
47.88
Volume
18,008 shs
Average Volume
63,247 shs
Market Capitalization
£17.46 million
P/E Ratio
25.68
Dividend Yield
2.18%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ALT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Altitude Group and its competitors with MarketBeat's FREE daily newsletter.

ALT Stock News Headlines

Banks aren’t ready for this altcoin—are you?
The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket change.
See More Headlines

ALT Stock Analysis - Frequently Asked Questions

Altitude Group's stock was trading at GBX 26.33 at the beginning of the year. Since then, ALT stock has decreased by 8.8% and is now trading at GBX 24.

Altitude Group plc (LON:ALT) released its quarterly earnings results on Tuesday, December, 3rd. The company reported $0.66 EPS for the quarter. Altitude Group had a trailing twelve-month return on equity of 6.70% and a net margin of 2.90%.

Shares of ALT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Altitude Group investors own include Revvity (PKI), AbbVie (ABBV), Bristol Myers Squibb (BMY), Agilent Technologies (A), Abbott Laboratories (ABT) and ACADIA Pharmaceuticals (ACAD).

Company Calendar

Last Earnings
12/03/2024
Today
7/10/2025

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Software - Application
Sub-Industry
Pharmaceutical Products
Current Symbol
LON:ALT
CIK
N/A
Fax
N/A
Employees
50
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX 0.93
Trailing P/E Ratio
25.68
Forward P/E Ratio
7.79
P/E Growth
N/A
Net Income
£682.34 thousand
Net Margins
2.90%
Pretax Margin
N/A
Return on Equity
6.70%
Return on Assets
1.65%

Debt

Debt-to-Equity Ratio
3.59
Current Ratio
1.99
Quick Ratio
2.36

Sales & Book Value

Annual Sales
£23.50 million
Price / Sales
0.74
Cash Flow
GBX 0.91 per share
Price / Cash Flow
26.29
Book Value
GBX 14.35 per share
Price / Book
1.67

Miscellaneous

Outstanding Shares
72,744,208
Free Float
N/A
Market Cap
£17.46 million
Optionable
Not Optionable
Beta
1.25
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (LON:ALT) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners